Hexatronic - Q2 2025 Preview – FX hurting

Redeye reduces its forecasts and Base Case in Hexatronic slightly on the back of FX and the revised BEAD. FX hurts Q2, while we expect the revised BEAD to have some negative mid/long-term impact.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/